Preventing drug-related adverse events following hospital discharge: the role of the pharmacist
- PMID: 29354552
- PMCID: PMC5774326
- DOI: 10.2147/IPRP.S104639
Preventing drug-related adverse events following hospital discharge: the role of the pharmacist
Abstract
Transition of care (ToC) points, and in particular hospital admission and discharge, can be associated with an increased risk of adverse drug events (ADEs) and other drug-related problems (DRPs). The growing recognition of the pharmacist as an expert in medication management, patient education and communication makes them well placed to intervene. There is evidence to indicate that the inclusion of pharmacists in the health care team at ToC points reduces ADEs and DRPs and improves patient outcomes. The objectives of this paper are to outline the following using current literature: 1) the increased risk of medication-related problems at ToC points; 2) to highlight some strategies that have been successful in reducing these problems; and 3) to illustrate how the role of the pharmacist across all facets of care can contribute to the reduction of ADEs, particularly for patients at ToC points.
Keywords: adverse drug events; drug-related problems; hospital discharge; pharmacist; transitions of care.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
References
-
- WHO [webpage on the Internet] Report of a WHO Meeting Tokyo. The Role of the Pharmacist in the Health Care System. [Accessed January 5, 2017]. Available from: http://apps.who.int/medicinedocs/en/d/Jh2995e/
-
- Bidwell S, Thompson L. GPs, community pharmacists and shifting professional boundaries. N Z Med J. 2015;128(1414):19–26. - PubMed
-
- Ministry of Health . Pharmacy Action Plan 2016 to 2020. Wellington: Ministry of Health; 2016.
-
- Nissen L, Campbell C. Be our guest: vaccination status of Australian community pharmacy. Aust Pharm. 2015;34(9):15.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources